首页> 外国专利> Identification and engineering modification of antibodies having mutant Fc region and methods of use thereof

Identification and engineering modification of antibodies having mutant Fc region and methods of use thereof

机译:具有突变Fc区的抗体的鉴定和工程修饰及其使用方法

摘要

The present invention relates to molecules, particularly polypeptides, more particularly immunoglobulins (e.g., antibodies), comprising a variant Fc region, wherein said variant Fc region comprises at least one amino acid modification relative to a wild-type Fc region, which variant Fc region binds Fc³RIIIA and/or Fc³RIIA with a greater affinity, relative to a comparable molecule comprising the wild-type Fc region. The molecules of the invention are particularly useful in preventing, treating, or ameliorating one or more symptoms associated with a disease, disorder, or infection. The molecules of the invention are particularly useful for the treatment or prevention of a disease or disorder where an enhanced efficacy of effector cell function (e.g., ADCC) mediated by Fc³R is desired, e.g. , cancer, infections disease, and in enhancing the therapeutic efficacy of therapeutic antibodies the effect of which is mediated by ADCC.
机译:本发明涉及包含变异Fc区的分子,特别是多肽,更特别是免疫球蛋白(例如抗体),其中相对于野生型Fc区,所述变异Fc区包含至少一个氨基酸修饰,该变异Fc区相对于包含野生型Fc区的可比分子,其以更大的亲和力结合Fc 3 RIIIA和/或Fc 3 RIIA。本发明的分子在预防,治疗或改善与疾病,病症或感染有关的一种或多种症状中特别有用。本发明的分子特别可用于治疗或预防需要由Fc 3 R介导的效应细胞功能(例如ADCC)的功效增强的疾病或病症,例如Fc 3R。 ,癌症,感染性疾病以及增强治疗性抗体的治疗功效,其效果由ADCC介导。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号